AI-enhanced robotic hands - a breakthrough in early tumour detection and removal

Sep 23, 2026

Uploaded by Ivy

AI-enhanced robotic hands are rapidly reshaping tumour surgery by combining real-time sensing, precision mechanics, and intelligent decision support, yet current systems face persistent limits in early lesion detection, tactile sensitivity, and cancer-type-dependent accuracy. This review examines next-generation robotic hands enabled by multimodal AI, augmented imaging, hybrid guidance, and minimally invasive mechatronics. Across multiple oncology domains, it synthesizes evidence on improved early tumour localization and safer resections, while highlighting tensions in cost-effectiveness, reproducibility, and adoption gaps. It recommends stronger validation, interoperable imaging ecosystems, and ethical design. Limitations include heterogeneous study designs and early prototypes, with future work targeting adaptive learning and broader trials.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages8

Reading Time20 min

AccessFree to download

Abstract

Introduction

Methods

Search strategy

Journal of Robotic Surgery (2026) 20:218 [https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1701-026-03159-1 REVIEW AI-enhanced robotic hands: a breakthrough in early tumour detection and removal Jack Ng1 · Kok Wah1 Received: 3 December 2025 / Accepted: 7 January 2026 © The Author(s) 2026 Abstract AI-enhanced robotic hands are rapidly reshaping tumour surgery by merging real-time sensing, precision mechanics, and intelligent decision support, yet current systems still struggle with early lesion detection, limited tactile sensitivity, and inconsistent accuracy across cancer types. This review addresses these gaps by examining how next-generation robotic hands, empowered by multimodal AI, augmented imaging, hybrid guidance, and minimally invasive mechatronics, can improve early tumour localization and safer resections. The study synthesizes insights from urologic, breast, colorectal, gastric, thoracic, and gynecologic oncology to highlight shared trends such as the shift toward personalized robotics, smart biopsy tools, light-mediated theranostics, flexible platforms, and real-time intraoperative analytics. A comparative reading of quantitative and qualitative evidence reveals strong gains in surgical precision and patient outcomes, yet also contradictions regarding cost-effectiveness, reproducibility of AI predictions, and disparity in adoption between high-and low-resource settings. Using a narrative review approach, key findings point to robotic hands with enhanced tactile sensors and AI-driven micro-maneuvering as promising breakthroughs for detecting microtumours, reducing positive margins, and guiding on-table diagnostics. Recommendations emphasize stronger clinical validation, interoperable imaging ecosystems, and ethical design. The implications extend to safer surgeries, shorter recovery, and more equitable cancer care. Limitations include heterogeneous study designs and early-stage prototypes. Future research should explore adaptive learning models, haptic-guided autonomy, and broader trials. Overall, AI-enhanced robotic hands signal a transformative pathway for earlier detection and more precise tumour removal. Keywords Robot-assisted tumor removal · AI in cancer surgery · Live imaging during surgery · Smart robot movement control · Less-invasive robotic cancer surgery Introduction The rapid convergence of artificial intelligence and surgical robotics is redefining cancer care, enabling earlier tumour detection and more precise interventions. Across multiple oncologic fields, AI-enhanced robotic systems equipped with advanced sensing, imaging, and decision-support technologies are transforming intraoperative vision and manipulation. Recent studies in urologic, breast, colorectal, gastric, and gynecologic surgery demonstrate substantial improvements in diagnostic accuracy, surgical precision, and patient 􀀍 Kok Wah [ngkokwah@mmu.edu.my](ngkokwah@mmu.edu.my) 1 Persiaran Multimedia, Multimedia University, Cyberjaya, Cyberjaya 63100, Selangor, Malaysia outcomes [1, 2, 4, 20, 21] . Increasingly, the literature also highlights real-time multimodal intelligence that allows surgeons to detect tumour margins earlier and execute targeted resections with greater confidence [3, 15, 18] . This momentum suggests an emerging shift toward robotic systems capable not only of handling instruments but also interpreting tissue characteristics directly. Despite such progress, major gaps persist. Current robotic platforms still rely heavily on surgeon-dependent visual interpretation, making subtle tumour boundaries and micro-lesions difficult to identify. While techniques such as hybrid surgical guidance and intraoperative Raman spectroscopy offer improved tumour confirmation, their use remains confined to specialised centres [9, 15] . Challenges also remain in complex anatomical regions where limited tactile feedback and delayed tissue characterisation restrict precision [5, 11] . Although augmented realit

FAQs

What key technical gaps limit current robotic systems for early tumour detection?

The review highlights difficulties with early lesion detection, limited tactile sensitivity, and inconsistent accuracy across cancer types.

How does the review propose next-generation AI-enhanced robotic hands improve tumour surgery?

It describes multimodal AI with augmented imaging, hybrid guidance, and minimally invasive mechatronics to support earlier tumour localization and safer resections.

What limitations and future research directions does the review emphasize?

Limitations include heterogeneous study designs and early-stage prototypes. Future work should explore adaptive learning models, haptic-guided autonomy, and broader trials, alongside stronger clinical validation and ethical design.

Sep 23, 2026

Uploaded by Ivy